Taiwan FDA registration 7d992a8c3c92ad2f4c543e76ebbd7d1f
"Sysmecon" erythrocytolytic agent II (unsterilized)
TW: “希森美康”紅血球溶解劑二代 (未滅菌)
Taiwan·Risk Class 1·SYSMEX CORPORATION;; SYSMEX CORPORATION Ono Factory·Registered May 17, 2022 – May 17, 2027ActiveRegistration details
- Analysis ID
- 7d992a8c3c92ad2f4c543e76ebbd7d1f
- Customs Code
- DHA09402280307
Company information
- Manufacturer Country
- Japan
- Authorized Representative
- SYSMEX TAIWAN CO., LTD.
Product details
- Intended Use
- Limited to the classification and grading management measures for medical devices, the first level identification range of "red blood cell lytic agent (B.8540)".
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.8540 紅血球溶解劑
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- May 17, 2022
- Expiry Date
- May 17, 2027
About this record
Access comprehensive regulatory information for "Sysmecon" erythrocytolytic agent II (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 7d992a8c3c92ad2f4c543e76ebbd7d1f and manufactured by SYSMEX CORPORATION;; SYSMEX CORPORATION Ono Factory. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices